1st Quarter - Report
DENDREON PHARMACEUTICALS, LLC for DENDREON PHARMACEUTICALS, LLC
Income
—
Expenses
$126,199
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Medicare Part B drug payment reform. Specifically, access to autologous cellular immunotherapies in Medicare Part B Access to Prostate Cancer Treatment Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act
Foreign entity interest: Dendreon, a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW SAELENS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.